And then there were three: a single shot vaccine is the latest weapon to join the battle against COVID-19 in the United States.
On February 27, the United States Food and Drug Administration granted emergency use authorization for Johnson & Johnson’s vaccine against SARS-CoV-2, the coronavirus responsible for COVID-19. South Africa is the only other country to have received the OK Johnson & Johnson vaccine to date, although other countries are on the verge of doing the same.
The FDA has determined that Johnson & Johnson’s vaccine meets criteria for safety and efficacy and that there is clear evidence that it can prevent COVID-19, the agency said in a statement.
“With today’s clearance, we are adding another vaccine to our medical toolkit to combat this virus,” said Peter Marks, director of the Center for Biologics Evaluation and Research at the FDA.
Its emergency use authorization in the United States – for people aged 18 and over – follows similar authorizations in December for vaccines manufactured by Moderna and by Pfizer and its German partner BioNTech.
Vaccine shortages make the addition of a safe and effective third vaccine welcome. “We’re still in the middle of this …
Read Additional From Source
Copyright @ www.sciencenews.org
News Highlights Science
- According to the source What you need to know about J&J’s FDA-cleared COVID-19 vaccine
- Check all news and articles from the Science news information updates.